<unk>  is a non-ergoline dopamine agonist that is FDA<unk> proved for the treatment of advanced Parkinson's disease.   Common adverse reactions include yawning, drowsiness/somnolence, dyskinesias, dizziness/postural hypotension, rhinorrhea, nausea and/or vomiting, hallucination/confusion, and edema/swelling of extremities.
Apomorphine
Azidomorphine
Nicomorphine
Droperidol
Lerisetron
Benperidol
Homatropine
Tropisetron